Why is OSCR up?
Up 520% over three years while the S&P 500 rose 89%.
- Revenue grew 43.5% a year against its 5 peers' median of 11.8%;
OSCR's Quality Score rose 1 point on Mon, Nov 2, to 14.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 520% over three years while the S&P 500 rose 89%.
| The company | Sales up 43% on the year |
| Latest filing | 10-Q, Aug 7 |
ReportReports Thursday, before the open. Every 3 months, a company tells everyone how much it sold and earned. It rose after 2 and fell after 2 of its last 4 reports, -0.6% on average. Past reports ›
After its last 4 reports it closed -0.6% on average, higher 2 of 4 times.
Above Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
OSCR is #2 of 10 by Quality Score among Hospital & Medical Service Plans.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score |
Share count against a year before: OSCR +18%, MOH -4.7%, ELV -3.6%, CNC +0.1%.
Reports Thu Nov 5, before the open (in 3 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“The increase was driven by higher membership and rate increases, partially offset by an increase in the net risk adjustment transfer accrual.”
OSCR's results filing gives no sales by line in a table we read.
No outlook figures read from this release.
“The significant increase reflects strong operating performance driven primarily by improved underwriting performance and favorable prior period development.”
From its results filing (SEC filing · Aug 6)
Sales grew 91% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 7.3% a year over 3 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 6, 2026 | -8.6% | -11.9% | -1.7% |
| May 6, 2026 | +2.8% | +10.6% | +32.3% |
| Feb 10, 2026 | +6.6% | +1.7% | +5.8% |
Sales grew in five of the last six years, to $12B in 2025. It lost money in 2025 after a profit in 2024.
2 insiders sold $23.4M across 3 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: OSCR is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
“We operate in a highly competitive environment in an industry subject to significant and ongoing changes, including business and hospital system consolidations, new strategic alliances, market pressures, scientific and technological advances in medical care and therapeutics, as well as regulatory and legislative challenges and reform both at the federal and state levels.”
OSCR scores 14 today, which Breakaway calls Above Average. It is #2 of 10 in Hospital & Medical Service Plans by Quality Score, with 3 of 14 chart checks firing. Up 520% over three years while the S&P 500 rose 89%. Shares: 18.3% more than a year ago (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
OSCR scores 14 today, which Breakaway calls Above Average (11 to 14). That is #2 of 10 in Hospital & Medical Service Plans by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind OSCR's 14.
2 insiders sold $23.4M across 3 filings in the last 6 months. No open-market buys on record. The newest is Mario Schlosser, Director, who sold $18.2M on Aug 27. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.